Name: Kidney 2023
Start: 2023-03-06
End: 2023-03-08
Location: Dubai

Conference Information

Welcome message

Greetings!

On March 6–8, 2023, in Dubai (UAE), we kindly invite you to our 2nd International Conference on Kidney and Renal Biomarkers conference.

This year's innovation theme, "Exploring new research and innovative development in Nephrology and Renal Biomarkers," sets the door for information to be gathered.

An international conference offers a customary forum for scientists and academics from several countries to exchange information. Additionally, it provides opportunities for the affiliated organizations to communicate about their most recent developments, and, in addition, it allows people to become aware of their organizations, which will afterward increase their notoriety. All-hand meetings and presentations of posters by international experts. Connect with young researchers and analysts to lead more in-depth investigations that will pave new paths for a superior world.

It offers the opportunity to meet recognized personalities from industry and science and to build a scientific network with them. The impact of this international conference will be an exceptional experience, with pioneers showing the best expression on the most notable points.

At this conference, you will have the opportunity to connect with exceptionally talented scholars from around the world, present your research and talk to your friends. At this conference, you will have the opportunity to connect with exceptionally talented scholars from around the world, present your research and talk to your friends.

The conference of the 2nd World Kidney and Renal Biomarker Congress brings together scientists, doctors, researchers, and university professors consisting of lectures, oral and poster presentations, exhibitions, and much more knowledge, share your experiences of research and receive name recognition and certificates signed by our exceptional Organizing a world-class committee.

This event features keynote speakers and engaging content. This event will help delegates interact with scientists. Save the link to confirm the conference and gather ideas and information.

The program is already well advanced and the networking opportunities will be truly excellent. The meet also aims to provide its attendees with attractive feature addresses, appropriate banners and oral presentations, engaging presentations, lavish sponsorship openings, and coordinated media efforts and affiliations.

The cleaning panel went out of its way to organize a useful meeting. nephrology 2023 not only provides a forum for the exchange of views among a large group of people but also strives to disseminate new ideas and discoveries in the clinical, theoretical, and physiological fields of medicine and design.

We look forward to seeing you at the conference in Dubai, United Arab Emirates.

About Conference

The 2nd International Conference on Kidney and Renal biomarkers 2023. The year 2023 is meant to inspire greater cooperation and provide a platform for connecting individuals from around the world for the exchange of ideas under the theme “Exploring new research and Innovative Development in Nephrology and Renal Biomarkers”.

It is the best platform to have the discussion and the innovative researches and developments in the field of cluster of Nephrology and Urology.

We are happily welcome you to the 2nd International Conference on Kidney and Renal Biomarkers will be held in March 06-08, 2023 at Dubai, UAE.

Targeted Audience

Nephrologist Doctors
Nephrologist Assistant Professors
Healthcare Researchers
Ph.D. Students
Physicians
Nurses
Pharmacists
Allied Health Professionals
Industrialist
Young Researchers
Global experts in the Nephrology and Urology
Scientists
Expert from the background of Clinical Nutrition and Dieticians

Sessions and Tracks

Track 1: Clinical nephrology

It is the field that studies accurate diagnosis and promotes the treatment of Kidney disease. It examines inflammation, chronic diseases, medications, complications of various diseases, hypertension, the impact of hypertension on Kidney function, and the impact of diabetes mellitus on the renal system. It examines the ability of the Kidney to filter harmful components from the blood in a healthy way. A nephrologist examines electrolyte imbalances (electrolyte imbalance disorders), such as an imbalance of sodium, potassium, or calcium in the body.

In the laboratory, clinical nephrology uses modern technologies to treat and diagnose Kidney disease. It includes the study of the Kidney, its functions, and diseases, as well as the diagnosis and treatment of various human problems. Clinical nephrology mainly deals with nephrological problems in adults and the elderly. Kidney cystectomy is surgery to remove an abnormal bladder or cyst. Warfarin-related nephropathy is a relatively recent development in clinical nephrology that combines the treatment of Kidney disease with the use of warfarin.

Sub Tracks:

Proteinuria.
Nephritic Syndrome.
Membranous Glomerulonephritis.
Calcification.

Associated Societies

Related Journals

Track 2: Urology

Urologists are Kidney specialists who generally focus on the anatomical aspects of the urinary tract and the male reproductive system. If necessary, they also perform corrective surgeries.Urology deals with surgical treatments, unlike nephrology. This is also one of the main differences. A master's degree in surgery is therefore required for subspecialty training in urology. On the other hand, a nephrologist studies for a master's degree in general medicine and then receives a residency in nephrology. Its strength is non-invasive diagnosis and treatment.

Urological diseases and conditions include urinary tract infections, Kidney stones, bladder control problems, and prostate problems. Some urological Kidney problems are temporary, while others persist over a long period. Your body's drainage system for eliminating pee is the urinary tract. Urine is made up of both waste and water. The urinary tract includes the Kidneys, ureters, and bladder. To urinate normally, the urinary tract must work together in the correct order.

Sub Tracks:

Bladder control problems (urinary incontinence)
Bladder infection (UTI) in adults.
Bladder infection (UTI) in children.

Associated Societies

Related Journals

Track 3: Acute Interstitial Nephritis

Acute interstitial nephritis (AIN) Kidney is a common cause of acute Kidney injury, considering Kidney biopsies performed due to this condition. Overall, renal drug-induced AIN is currently the most common etiology of AIN, with antimicrobials and non-steroidal anti-inflammatory drugs being the most common damaging agents. Pathogenesis is based on an immune response against endogenous nephritogenic antigens or exogenous antigens processed by tubular cells, in which cell-mediated immunity plays an important pathogenic role. Characteristic interstitial infiltrates, usually composed of lymphocytes, macrophages, eosinophil’s, and plasma cells, undergo rapid transformation into areas of interstitial fibrosis.

A significant proportion of renal AINs today have an oligosymptomatic presentation, although the presence of specific extra renal symptoms such as fever, rash, arthralgia, and peripheral eosinophilia plays an important role in guiding the clinical diagnosis. Identifying and eliminating the Kidney-damaging drug is the mainstay of treatment, but recent studies strongly suggest that early administration of steroids improves recovery of Kidney function and reduces the risk of chronic Kidney disease. Delayed treatment with steroids for interstitial fibrosis would have little or no therapeutic benefit.

Sub Tracks:

Glomerulonephritis
Chronic tubulointerstitial nephritis.
Interstitial nephritis
Acute Kidney injury

Associated Societies

Related Journals

Track 4: Clinical diagnosis of Lupus Nephritis

Urinary sediment is also useful in characterizing renal disease activity in the Kidney since the presence of haematuria, leukocyturia, or casts is typical only during periods of disease activity. Interestingly, erythrocyte cylinders were only present in thirty-nine renal cases. In descending order, the most common abnormal urine or Kidney sediment findings in LN are leukocyturia, haematuria, granular casts, and hyaline casts.

Increased renal anti-DNA antibody titters and hypo complementation, especially with low C3 complement, are strong indicators of active lupus Kidney disease, although serology cannot be used in isolation to diagnose or monitor Kidney disease. Hypoalbuminemia with prominent proteinuria is a component of nephritic Kidney syndrome that may accompany active lupus Kidney disease.

Hypercholesterolemia is another marker and clinical complication of nephritic syndrome that can actively accompany it.

The importance of tubulointerstitial lesions in the LN is increasingly recognized. In most patients, the severity of interstitial inflammation corresponds to the degree of glomerular involvement. Tubular damage, fibrosis, and atrophy may be associated with hyperuricemia and renal tubular acidosis.

Sub Tracks:

Minimal meningeal glomerulonephritis.
Meningeal proliferative glomerulonephritis
Systemic lupus erythematous
Kidney failure
Autoimmune disease

Associated Societies

Related Journals

Track 5: chronic Kidney disease

Patients with chronic Kidney disease (chronic Kidney disease) often face neurological complications. These complications can affect both the central and peripheral nervous systems. Common neurological complications in chronic Kidney disease include stroke, cognitive dysfunction, encephalopathy, and peripheral and autonomic neuropathies. These conditions have a significant impact not only on patient morbidity but also on mortality risk through a variety of mechanisms. Understanding the pathophysiological mechanisms of these disorders can provide information on effective management strategies for neurological complications. This review describes the clinical management of neurological complications in chronic renal failure concerning contributing physiological and pathological disorders. Stroke, cognitive dysfunction, and dementia share multiple disease mechanisms that can contribute to vascular impairment and neurodegeneration.

Cognitive dysfunction and dementia can be distinguished from encephalopathy, which has similar contributing factors but presents acutely and rapidly, and gradually and may be accompanied by tremors and asterisks. Treatment of painful neuropathic symptoms can be achieved by pharmacological agents with careful dosage and taking into account side effects in case of renal failure. Neurological complications often become clinically apparent in the later stages of the disease, but early detection and treatment of these conditions in mild chronic Kidney disease can reduce their impact in later stages.

Sub Tracks:

Blockages in the blood vessels
Alport syndrome
Amyloidosis.
Kidney disease
Fabry disease.

Associated Societies

Related Journals

Track 6: Polycystic Kidney Diseases

Epithelial cell proliferation, abnormal fluid secretion, and excessive deposition of the extracellular matrix are the main features of cystic epithelial cells. These changes are accompanied by changes in the per cystic blood and lymphatic microvasculature. Most cysts detach from the tubules from which they form and fill with fluid through trans epithelial secretion. Enlargement of the cyst also compresses the surrounding nephrons, interstitial and vascular system. The blocked nephrons eventually form tubular glomeruli and apoptotic proximal tubules.

These events are associated with the production of chemokine’s, cytokines, and growth factors by epithelial cells, interstitial fibroblasts, and inflammatory cells, such as macrophages. Abnormal cytokine-mediated crosstalk between epithelial and inflammatory cells promotes increased inflammation and fibrosis, new cyst formation, and disease progression, resulting in massive end-stage renal fibrosis. Increased inflammation is likely an early event in disease progression, and selective macrophage depletion in the Kidneys of a mouse model resulted in a significant improvement in the cystic phenotype and an improvement in renal function.

Sub Tracks:

Autosomal dominant polycystic Kidney disease
Autosomal recessive polycystic Kidney disease
Growth of numerous cysts
Autosomal recessive polycystic Kidney
Treat haematuria.

Associated Societies

Related Journals

Track 7: Nephritic Syndrome

Nephritic syndrome is characterized by intermittent enema associated with significant proteinuria, low levels of certain plasma proteins, particularly albumin and gamma globulin, and hyperlipemia. The nephritic syndrome can occur as a phase of classic glomerulonephritis or as part of certain systemic diseases that are not primarily renal.

Proteinuria in the Kidney of the patient with nephritic syndrome is attributed to an impairment of the glomerular membrane that allows large amounts of protein to enter the glomerular fluid, and the main cause of hypoproteinaemia is attributed to the urinary excretion of proteins.

In patients with nephritic syndrome, renal serum concentrations of low-density beta-lipoproteins, which are rich in triglycerides, cholesterol, and phospholipids, are usually elevated. The cause of these Kidney changes is not known, but recent evidence suggests they may be related to the loss of plasma albumin in the urine.

Enema in patients with renal nephritic syndrome results from greater tubular reabsorption of filtered sodium chloride and water in the Kidneys than is necessary to maintain a normal volume of extracellular fluid. It has not been resolved whether the primary change is a renal decrease in glomerular filtration rate or an increase in tubular reabsorption.

A review of the course of patients with nephritic Kidney syndrome highlights the chronic nature of the disease.While general treatment measures are of great practical importance, issues related to the use of corticotropin or adrenal corticosteroids are currently of greater concern. Current evidence suggests that these agents should be used to induce diuresis and then administered over a long period.

Sub Tracks:

Severe swelling
Proteinuria
Steroid sensitive
Foamy urine
Fatigue

Associated Societies

Related Journals

Track 8: Kidney Biopsy

The standard or majority configuration of the renal arterial vasculature usually begins with a single artery that divides into anterior and posterior branches. All renal arteries are terminal arteries with no appreciable collateral arteries supplying the same vascular bed. The distal arterioles end where the anterior and posterior supply areas meet. This area, usually located along the poster lateral side of the Kidney and called the Hytrol or Broder line, is theoretically the safest place to obtain Kidney tissue samples for untargeted biopsies. This area of â€‹â€‹relative hypo vascularization is not visible in medical imaging studies.

The normal native Kidney is located in the retroperitoneal space. Whenever possible, biopsies of native Kidneys should be performed so that the needle only enters this space to reduce complications. Inserting a needle through the central hilum of the Kidney, where the larger arteries, veins, and calyces are located, should also be avoided. For non-targeted biopsies, sampling the renal cortex is generally preferred to oversampling the renal marrow because this is where most of the glomeruli used for evaluation are located.

Sub Tracks:

Needle biopsy
Ultrasound or computerized tomography
Macroscopic haematuria
Peptic ulcers
Endometriosis

Associated Societies

Related Journals

Track 9: Renal Cell Carcinoma

A challenge in the treatment of Kidney cancers is the range of histological and tumor phenotypes that a Kidney mass can represent. A Kidney tumor can range from benign to clinically indolent malignancy to aggressive disease. Even among different subtypes, Kidney cancers are genetically different with varying prognoses and response rates to treatment. Therefore, the key to adequate treatment is the differentiation of these subtypes. There is currently a wide variety of diagnostic, prognostic, and predictive biomarkers that can aid in the individualized care of patients with renal cell carcinoma. This review addresses the various serum, urine, imaging, and immunobiological biomarkers available in practice.

Sub Tracks:

Hippel-Lindau disease
Kidney Cancer
Immunotherapy
Targeted therapy
Amyloidosis

Associated Societies

Related Journals

Track 10: Renal Biomarkers Transplantation

Adhesion to renal immunosuppressants is not known to occur after renal transplantation, but the extent of the effect on transplant survival is unknown. Thirty-six studies of Kidneys meeting the inclusion criteria for further evaluation were grouped into cross-sectional and cohort studies and case series. Meta-analysis was used to estimate the magnitude of the impact of the non-compliance on graft failure. Only two studies measured adherence using electronic tracking, which is currently considered the most accurate measure.

Standardized renal methods should be developed to assess adherence in clinical populations and future studies should seek to identify the level of adherence that increases the risk of graft failure. However, the renal evaluation shows that adherence is uncommon and has a major impact on graft survival. Therefore, significant improvements in graft survival can be expected from effective interventions to improve adherence.

Sub Tracks:

Antibody.
Graft Survival.
Immunosuppressive Treatment.
Cyclosporine.
Transplantation

Associated Societies

Related Journals

Track 11: Osmolality Regulation

Renal plasma osmolality is tightly regulated and maintained. A change in water intake and excretion maintain normal plasma osmolality. At a steady state, the combination of water intake and water produced by the body through oxidation compensates for water losses from the skin, lungs, urine, and gastrointestinal tract. intestinal (GI). Only water intake and urine loss can be regulated.

Osmoreceptors in the hypothalamus detect plasma osmolality. Greater effective osmolality leads to the secretion of antidiuretic (ADH) by neurons in the supraoptic and periventricular nuclei in the hypothalamus. The axons of these neurons end in the posterior pituitary gland. Circulating renal ADH binds to its V2 receptors in renal collecting duct cells and causes water channels to be introduced into renal collecting duct cells. This provides greater water permeability, allowing water reabsorption in the hypertonic renal medulla.

Urine concentration increases and water excretion decreases. Urinary water loss cannot be eliminated because there is an obligatory excretion of urinary solutes such as urea and sodium. Regulation of renal ADH secretion is closely related to plasma osmolality, with the responses being a detectable change in osmolality. Renal ADH secretion virtually disappears when plasma osmolality is low, allowing the excretion of maximally dilute urine. The resulting loss of free water corrects plasma osmolality. ADH secretion is not an all-or-nothing reaction; there is a gradual adjustment as the osmolality changes.

Sub Tracks:

Dizziness when standing
Extreme thirst
Spasms or cramps
Seizures or passing out

Associated Societies

Related Journals

Track 12: Renal Therapeutic Theory

Many patients with mild to moderate ARI can be treated in general practice or surgical units, but patients with multiple organ failure should be treated in an intensive care unit. Patients with AKI who require renal replacement therapy should be treated either in a renal-rental unit or in an intensive care unit. There is currently little guidance for making decisions about when to initiate RRT in ARF. The options for RRT are usually continuous arterial-venous or venovenous hemofiltration.

Acute Kidney failure is a life-threatening condition. In a series of over a thousand patients requiring dialysis. However, when glomerulonephritis is present, the prognosis depends on the severity of the lesions and may be irreversible if too many glomeruli are affected. In such cases, the patient needs a Kidney to stay permanently on dialysis.

Sub Tracks:

Continuous Ven venous haemodialysis
Continuous Ven venous hemofiltration)
Continuous Ven venous hemodiafiltration
Atypical haemolytic uremic syndrome
Alport syndrome.
Amyloidosis.

Associated Societies

Related Journals

Track 13: Urology Robotic Surgery

Robotic surgery is a minimally invasive technique that is gaining popularity in surgery and especially in urology. Increasingly important renal urological procedures, such as radical prostatectomy and partial nephrectomies, are evolving towards minimally invasive laparoscopic and robotic techniques. Robotic Kidney surgery itself is constantly evolving to improve performance and minimize invasiveness.

Although this is a very recent technology, some preliminary experiences have been presented in the literature that documents the feasibility of some important urological interventions, including radical prostatectomy, radical cystectomy, partial nephrectomy, and ureterocystoneostomy.

The long-term oncological and functional results of the Kidney are not yet available and require further follow-up. In all cases, the single-port robotic system proved to be feasible and safe, albeit in small series. The reassessment of the development of robotic surgery aroused great enthusiasm with each innovation and led to wide dissemination of the method before the realization of randomized clinical trials which confirmed the effective improvement of the technique compared to the gold standard. The urological community should not miss a second chance to be able to evaluate a new technique based on comparative clinical studies.

Sub Tracks:

Robotic Kidney Surgery
Robotic Colorectal Surgery
Robotic prostate surgery
Removing adrenal gland tumours

Associated Societies

Related Journals

Track 14: Diabetic Patient on Dialysis

End-stage Kidney disease is the result of diabetes. There are a lot of problems that management of diabetic patients who receive dialysis must solve. People with diabetes are at a higher risk for cardiovascular events, Kidney problems, and mortality due to metabolic factors and accelerated vascular calcification. Diabetic haemodialysis patients have a high rate of haemodynamic instability which leads to Kidney organ ischemia and end organ damage; autonomic dysfunction of the Kidney seems to the presence of an important role in the haemodynamic instability and abnormal organ perfusion during haemodialysis can contribute to the development of these conditions. If your blood sugar levels are too high, you may experience fluid overload and a worse cardiovascular outcome. The main drivers for fluid overload in haemodialysis patients and in peritoneal dialysis are the chronic state of hyper hydration that is related to absorption of glucose from the PD fluids, protein loss and malnutrition, and the lack of fluid intake from the diet. The control of glycaemia is very important, and adjustments to diabetic medications need to be made in order to maintain good blood sugar levels. In haemodialysis, it is recommended to reduce the insulin dose to avoid hypoglycaemia; while in peritoneal dialysis, an increase in insulin dose is often necessary. The study found that diabetic dialysis patients are more likely to experience foot ulcers and Kidney infection than other groups. This information may help to identify cases of these diseases in patients early on. A multi-disciplinary approach is needed to provide efficient and effective care for diabetic patients on dialysis.

Sub Tracks:

Kidney failure
Kidney transplant
Micro albuminuria test
Protein electrophoresis

Associated Societies

Related Journals

Track 15: Interstitial Cystitis

Interstitial cystitis (IC) is a potentially serious Kidney and bladder disease. Many factors are involved in renal pathogenesis. A review of the Kidney literature was conducted on the following topics: urothelium, mucosal lining, interstitial cystitis, bladder and Kidney glycosaminoglycan. IC A commonly suggested cause of Kidney failure is defects or alterations in the bladder surface, leading to increased permeability to harmful urinary solutes, ultimately leading to tissue inflammation and renal neurogenic up regulation. Be connected. Support for this concept derives from studies of the structure, function, and composition of bubble surfaces. The cause of this change is unknown, but recent renal studies suggest altered levels of growth factors and/or compounds that protect against irritants and potential 'toxic' agents. Probably multifactorial.Alterations of the bladder surface are observed in IC and may play an important role in the ethology of this condition

Sub Tracks:

Top of Form
Bottom of Form
Hunner’s Lesions
Non- Ulcerative
Bladder Centric
Chronic Overlapping Pain conditions
Bladder Wall

Associated Societies

Related Journals

Track 16: Paediatric Urology

Antibiotics are the mainstay of treatment for bacterial Kidney infections, but their use is a major risk factor for the development of antibiotic resistance. Antimicrobial resistance is a growing problem in paediatric nephrology and urology, as evidenced by increased resistance to urinary tract disorders. Lack of urinalysis, indiscriminate use of prophylactic drugs, and poorly experienced prescribing practices exacerbate this Kidney problem. This article provides an overview of antibiotic use in paediatric urology and highlights patterns of practice that may be modified to mitigate the increasing rate of antibiotic resistance. Advice on selective use of antibiotic prophylaxis and importance of compliance in patients with severe vesicoureteral reflux and hydronephrosis; topical antibiotic testing using inpatient and outpatient renal data, especially in children. Use of specific antibiotic testing.

Sub tracks:

Infection
Bladder Infections
Frequent Urination
Bacterial Infection

Associated Societies

Related Journals

Market Analysis

The market for Kidney function tests was valued at USD 777.06 million in 2020, and it is anticipated to increase at a CAGR of 6.2% from 2021 to 2028.

With a market share of more than 40% in Kidney transplants, the United States led the world in 2015. More than 40 thousand Kidney transplants were performed in 2015 in the ten nations covered by the survey. Brazil performs more Kidney transplants than any other country, with a 10% share. In terms of Kidney transplantation rates, the United Kingdom is in third place. In 2015, France and Mexico are in fourth and fifth place, respectively.

Chronic Kidney disease (chronic Kidney diseases) affects 10% of the world’s population and millions die due to the lack of affordable treatments options. Over 2 million people worldwide currently receive treatment with dialysis or a Kidney transplant to stay alive, yet this number may only represent 10% of people who need treatment.

The significant economic burden of chronic Kidney disease has made it a global public health issue. The National Institutes of Health (NIH) estimate that 14.0% of people worldwide have chronic Kidney diseases. Additionally, due to changes in lifestyle, the prevalence of chronic Kidney diseases risk factors like diabetes, hypertension, and obesity is rising. Due to the rising need for chronic Kidney diseases screening tests that are now required in patients with diabetes and hypertension, there is a significant demand for the products. The International Diabetes Federation said that 463, 0 million persons worldwide had diabetes in 2019, and that number is expected to rise to 700 million by 2045.

The production of hormones like erythropoietin, 1,25-dihydroxyvitamin D, and renin, as well as the efflux of by-products and toxins like urea, creatinine, and uric acid, depend on the kidneys. The kidneys are also responsible for the regulation of extracellular fluid volume, serum osmolality, and electrolyte concentration levels.

The market value for renal function tests was around 21% of the global urinalysis market, which was valued at ~US$ 3.7 Bn in 2021. Sales of renal function tests expanded at a CAGR of 4.8% from 2012 to 2021. One of the significant reasons accelerating growth in the renal function test market is the increasing demand for accurate detection of kidney illnesses.

Rising prevalence of underlying diseases like diabetes and hypertension can spur the risk of development of new chronic diseases like chronic kidney disease (CKD). Increasing awareness of kidney function testing techniques and ongoing technological advancements in the field of diagnostic tools & equipment are also expected to drive growth in the market.

However, growing global burden of CKD is attributed to the rising prevalence of diabetes and excessive blood pressure. Growth in the market during the evaluation period would eventually be impacted by the rising number of diabetes cases.

Nephron, which includes the glomerulus, proximal & distal tubules, and collecting duct, is the functional unit of the kidney. In the treatment of patients with kidney disease or other illnesses that impact renal function, assessment of renal function is crucial. Renal function tests are helpful in detecting the presence of renal illness, tracking the kidneys' healing progress, and figuring out how the disease is progressing.

For instance, about 537 million adults (20-79 years old) or around 1 in 10 people were living with diabetes in 2021, according to the International Diabetes Atlas 10th edition. It is expected that this figure would increase to 643 million by 2030 and 783 million by 2045.

These above-mentioned factors are cumulatively contributing to the increasing demand for renal tests. Thus, the global renal function test market is anticipated to grow at a CAGR of 5.6% during the forecast period from 2022 to 2032.

Expanding research & development (R&D) activities for the creation of innovative products are anticipated to significantly accelerate the renal function test market expansion in the coming decade. Growing investments in the renal function testing industry are also anticipated to boost market expansion. To develop the first urine test for kidney cancer, Sweden-based Elypta AB raised a seed financing of US$ 7.0 Million in January 2020. The renal function test market expansion will also be supported by growing investments, launch of newer renal disease therapies, and more government initiatives to address abnormal kidney functioning.

Diabetes and high blood pressure are the most frequent causes of CKD. There are no symptoms in the early stages of CKD. End-stage kidney disease, often known as acute kidney failure, is a possible outcome of the illness. This happens when kidney function declines to the point where dialysis or kidney transplantation is necessary to preserve health and even life, which commonly happens when kidney function is 10% or less than typical renal dysfunction.

The renal function test market is set to witness a slowdown in terms of growth due to stringent government norms regulating the use of specific techniques in kidney tests, while a slowdown could also be caused by adverse healthcare changes. Additionally, authoritarian synchronization and the high cost of kidney disease testing methods are the main issues that are expected to restrain growth in the renal function test market.

A Kidney transplant is dependent on a variety of circumstances and conditions, such as Kidney failure brought on by a variety of causes (Kidney trauma, severe dehydration). It is not a common practise in many nations because a human can survive for years on just one Kidney. Additionally, the inability to pay for a Kidney transplant treatment is another barrier for those living in developing nations. One of the key elements influencing the number of Kidney transplant procedures is the availability of a donor. The market for Kidney transplants is projected to be worth US$ 81,037 million in 2021 and to grow at a CAGR of 3.1% to US$ 1,06,179 million by 2028. .

The clearance tests market category had a market share of 28.73% in 2020 and is anticipated to maintain its dominance over the study period. The most accurate way to monitor and gauge glomerular filtration rate is using clearance testing. These items include tests for creatinine and inulin, which are a crucial supplement to conventional diagnostic procedures for getting accurate results. Additionally, these tests' top-notch sensitivity and precision guarantee that there is little variance in performance. These items' low prices and simple accessibility on the market encourage greater usage. Over the projected period, the urine test segment is anticipated to grow at the fastest rate. This can be attributable to the numerous uses for these items, which include the detection of.

Past Conference Report

We want to express our gratitude to all of our collaborators and members of the organising committee for their on-going support. Without the assistance of our Media Partners, who assisted us in advertising this event, it would not have been feasible. We are grateful to our media partners for helping us reach a wider audience.

We also want to express our gratitude to all of the speakers, poster presenters, and delegates who gave of their time to share their research with our network of peers. We are thrilled to have forged such strong bonds with all of these attendees and associations, and we anticipate receiving much more support at our next events.

Annual Nephrology 2019 extends its sincere gratitude to institutions like our esteemed Media Partners and other illustrious individuals who supported the conference by promoting it through various online and offline channels, enabling it to reach every corner of the world. Additionally, it was an honour to thank the keynote speakers, organising committee members, chairs, and co-chairs that helped to make this event possible.

The "2nd International Conference on Kidney and Renal Biomarkers," which will be held on March 06–08, 2023 in Dubai, UAE, is the next event in the Annual Nephrology series, and Pulsus Conferences is pleased to announce it.

We'd like to thank you everyone for attending the “2^nd International conference on Kidney and Renal biomarkers”.

2^nd International Conference on
Kidney and Renal Biomarkers

Quick Links

Theme: Exploring new Research and Innovative Development in Nephrology and Renal Biomarkers

Conference Information

Welcome message

About Conference

Sessions and Tracks

Market Analysis

Past Conference Report